What was Braskem's Consolidated Recurring EBITDA for Q1 2026, and what drove the increase?

Braskem's Consolidated Recurring EBITDA for Q1 2026 was US$192 million, representing a 76% increase year-on-year. This improvement was driven by stronger performance in its Brazil/South America and US/Europe operations.

What are the three major financial and operational risks currently facing Braskem according to the report?

Braskem faces three major risks: (1) high leverage, with an Adjusted Net Debt/Recurring EBITDA ratio of 16.81x; (2) ongoing liability related to the Alagoas geological event, with R$3.367 billion remaining in provisions; and (3) debt restructuring challenges at its subsidiary Braskem Idesa, which has missed interest payments on its 2029 and 2032 notes and may pursue Chapter 11 proceedings.

Braskem Q1 2026 EBITDA Rebounds, But Leverage and Alagoas, Idesa Risks Remain High

May 14, 2026

Braskem reported a 76% increase in Q1 2026 EBITDA to $192 million, though high leverage and potential Chapter 11 proceedings for subsidiary Idesa pose significant risks.

Stock Titan

2026-05-06

Braskem Posts Mixed 1Q26 Operational Performance as Core Petrochemical Utilization Improves but Mexico and Green PE Weaken

2026-05-06

Braskem (NYSE: BAK) details 2026 results dates and shareholder meeting

2026-05-09

Rosen Law Firm Files Securities Class Action Against Braskem S.A.

2026-05-11

Braskem Names Two New Next-Generation Tankers for Cleaner Naphtha Trade

2026-05-14

Braskem: Q1 Earnings Snapshot